I agree that this site is using cookies. You can find further informations here.
X
Brannagan, TH
6  results:
Search for persons X
?
1

Inotersen Improves Quality of Life and Neuropathy in Patien..:

Berk, JL ; Coelho, T ; Wang, AK...
Value in Health.  21 (2018)  - p. S202 , 2018
Link: https://doi.org/10.1016/..
 
?
2

Long-term safety and efficacy of patisiran for hereditary t..:

Adams, D ; Polydefkis, M ; González-Duarte, A...
https://discovery.ucl.ac.uk/id/eprint/10117722/3/Gillmore_LANCETNEUROL-D-20-00074%20accepted%20version.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
?
3

ATTR amyloidosis during the COVID-19 pandemic: insights fro..:

Brannagan, TH ; Auer-Grumbach, M ; Berk, JL...
https://discovery.ucl.ac.uk/id/eprint/10128086/1/s13023-021-01834-0.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
?
4

Quality of life outcomes in APOLLO, the phase 3 trial of th..:

Obici, L ; Berk, JL ; González-Duarte, A...
https://discovery.ucl.ac.uk/id/eprint/10093294/1/11_03_2020_Quality%20of.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
5

Patisiran, an RNAi Therapeutic, for Hereditary Transthyreti..:

Adams, D ; Gonzalez-Duarte, A ; O'Riordan, WD...
https://discovery.ucl.ac.uk/id/eprint/10053003/5/nejmoa1716153.pdf.  , 2018
Link: https://discovery.ucl.ac..
 
?
6

Assessing mNIS+7Ionis and international neurologists' profi..:

Dyck, PJ ; Kincaid, JC ; Dyck, PJB...
https://discovery.ucl.ac.uk/id/eprint/10077908/1/nihms-841384.pdf.  , 2017
Link: https://discovery.ucl.ac..
 
1-6